• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vanda Pharmaceuticals Inc. - Common Stock (NQ:VNDA)

7.160 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7
Open 7.160
Bid (Size) 7.050 (200)
Ask (Size) 7.400 (200)
Prev. Close 7.160
Today's Range 7.160 - 7.160
52wk Range 3.809 - 9.940
Shares Outstanding 55,638,166
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Vanda Now Looks To Public Hearing For Hetlioz In Jet Lag Disorder After Multiple FDA Rejections ↗
March 03, 2026
According to Vanda, the FDA has not granted such a hearing in the context of drug approvals for potentially over 40 years. 
Via Stocktwits
News headline image
Vanda Pharma Stock Rises Pre-Market After FDA Accepts Imsidolimab Filing For Rare Skin Disorder ↗
February 25, 2026
The company noted that if the FDA approves its application, Imosidolimab could address a significant unmet medical need in this rare and life-threatening disorder. 
Via Stocktwits

Performance

YTD
-13.2%
-13.2%
1 Month
-18.7%
-18.7%
3 Month
-3.4%
-3.4%
6 Month
+36.9%
+36.9%
1 Year
+64.2%
+64.2%

More News

Read More
In today's session, these stocks are experiencing unusual volume. ↗
February 24, 2026
Via Chartmill
Let's take a look at the stocks that are in motion in today's session. ↗
February 23, 2026
Via Chartmill
Why Did Vanda Pharmaceuticals Stock Slide 7% Pre-Market Today? ↗
February 12, 2026
Via Stocktwits
Vanda Pharmaceuticals Inc (NASDAQ:VNDA) Stock Plummets 9.8% After Mixed Q4 2025 Earnings Report ↗
February 11, 2026
Via Chartmill
Vanda Stock Drop 10% Premarket After FDA Rejects Jet Lag Drug Application ↗
January 08, 2026
Via Stocktwits
Here are the top movers in Monday's session. ↗
February 23, 2026
Via Chartmill
These stocks are gapping in today's session ↗
February 23, 2026
Via Chartmill
These stocks are moving in today's pre-market session ↗
February 23, 2026
Via Chartmill
News headline image
Nasdaq, S&P 500 Futures Fall On Tariff, Iran Tensions: Why NVDA, NFLX, HON, IBRX, MLTX Are On Traders' Radar Today ↗
February 23, 2026
Via Stocktwits
Topics Artificial Intelligence ETFs Government
News headline image
VNDA Stock Soars 40% Overnight After Bysanti Approval: What’s The Next Catalyst And How Much Upside Remains? ↗
February 22, 2026
Via Stocktwits
News headline image
VNDA Stock Rallies After-Hours As FDA Approves Schizophrenia, Bipolar Disorder Drug ↗
February 20, 2026
Via Stocktwits
News headline image
Vanda Stock Draws Heavy Buzz Ahead Of FDA Verdict On Bysanti For Bipolar, Schizophrenia ↗
February 19, 2026
Via Stocktwits
News headline image
Vanda (VNDA) Q4 2025 Earnings Call Transcript ↗
February 11, 2026
Via The Motley Fool
Topics Earnings
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vanda Pharmaceuticals Inc. - VNDA
February 03, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Vanda Pharmaceuticals Inc. - VNDA
January 27, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Vanda Pharmaceuticals Inc. - VNDA
January 20, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vanda Pharmaceuticals Inc. - VNDA
January 13, 2026
From Pomerantz LLP
Via GlobeNewswire
Get insights into the top gainers and losers of Thursday's pre-market session. ↗
January 08, 2026
Via Chartmill
In today's session, these stocks are experiencing unusual volume. ↗
January 02, 2026
Via Chartmill
News headline image
What's Going On With Vanda Pharmaceuticals Stock Wednesday? ↗
December 31, 2025
Via Benzinga
Here are the top movers in Wednesday's session. ↗
December 31, 2025
Via Chartmill
Top movers analysis in the middle of the day on 2025-12-31: top gainers and losers in today's session. ↗
December 31, 2025
Via Chartmill
The market is filled with gapping stocks in Wednesday's session. ↗
December 31, 2025
Via Chartmill

Frequently Asked Questions

Is Vanda Pharmaceuticals Inc. - Common Stock publicly traded?
Yes, Vanda Pharmaceuticals Inc. - Common Stock is publicly traded.
What exchange does Vanda Pharmaceuticals Inc. - Common Stock trade on?
Vanda Pharmaceuticals Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Vanda Pharmaceuticals Inc. - Common Stock?
The ticker symbol for Vanda Pharmaceuticals Inc. - Common Stock is VNDA on the Nasdaq Stock Market
What is the current price of Vanda Pharmaceuticals Inc. - Common Stock?
The current price of Vanda Pharmaceuticals Inc. - Common Stock is 7.160
When was Vanda Pharmaceuticals Inc. - Common Stock last traded?
The last trade of Vanda Pharmaceuticals Inc. - Common Stock was at 04/13/26 04:00 PM ET
What is the market capitalization of Vanda Pharmaceuticals Inc. - Common Stock?
The market capitalization of Vanda Pharmaceuticals Inc. - Common Stock is 398.37M
How many shares of Vanda Pharmaceuticals Inc. - Common Stock are outstanding?
Vanda Pharmaceuticals Inc. - Common Stock has 398M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap